Eledon Pharmaceuticals, Inc. (ELDN)
$2.48+2.48%Close
SELLCRISIS · day 30
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $191M
- Beta
- 0.94
- P/E (TTM)
- -2.47
- Short % float
- 14.41%
- Days to cover
- 8.8
- SI change
- -5.0%
- 1W
- -0.40%
- 1M
- -10.79%
- vs SPY 1W
- -1.56%
- vs SPY 1M
- -13.78%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ELDN?
- LOPJLB’s latest quantitative signal on Eledon Pharmaceuticals, Inc. (ELDN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ELDN in?
- Eledon Pharmaceuticals, Inc. (ELDN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Eledon Pharmaceuticals, Inc. (ELDN) do?
- Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protei…